These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 12187087

  • 1. The Decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes.
    De Cosmo S, Tassi V, Thomas S, Piras GP, Trevisan R, Cavallo Perin P, Bacci S, Zucaro L, Cisternino C, Trischitta V, Viberti GC.
    Nephron; 2002 Sep; 92(1):72-6. PubMed ID: 12187087
    [Abstract] [Full Text] [Related]

  • 2. A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria.
    De Cosmo S, Argiolas A, Miscio G, Thomas S, Piras GP, Trevisan R, Perin PC, Bacci S, Zucaro L, Margaglione M, Frittitta L, Pizzuti A, Tassi V, Viberti GC, Trischitta V.
    Diabetes; 2000 Mar; 49(3):521-4. PubMed ID: 10868979
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S, Blohmé G, Sylvén C, Mulec H.
    Nephrol Dial Transplant; 1997 Mar; 12 Suppl 2():67-70. PubMed ID: 9269704
    [Abstract] [Full Text] [Related]

  • 5. ACE, PAI-1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes.
    De Cosmo S, Margaglione M, Tassi V, Garrubba M, Thomas S, Olivetti C, Piras GP, Trevisan R, Vedovato M, Cavallo Perin P, Bacci S, Colaizzo D, Cisternino C, Zucaro L, Di Minno G, Trischitta V, Viberti GC.
    Diabetes Metab Res Rev; 1999 Mar; 15(4):247-53. PubMed ID: 10495473
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy.
    Möllsten A, Wessman M, Svensson M, Forsblom C, Parkkonen M, Brismar K, Groop PH, Dahlquist G.
    Ann Med; 2006 Mar; 38(7):522-8. PubMed ID: 17101543
    [Abstract] [Full Text] [Related]

  • 8. The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression.
    De Cosmo S, Miscio G, Zucaro L, Margaglione M, Argiolas A, Thomas S, Piras G, Trevisan R, Perin PC, Bacci S, Frittitta L, Pizzuti A, Tassi V, Di Minno G, Viberti G, Trischitta V.
    Nephrol Dial Transplant; 2002 Aug; 17(8):1402-7. PubMed ID: 12147786
    [Abstract] [Full Text] [Related]

  • 9. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
    Lehmann R, Spinas GA.
    Praxis (Bern 1994); 1995 Oct 31; 84(44):1265-71. PubMed ID: 7491450
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Polymorphisms in the nephrin gene and diabetic nephropathy in type 1 diabetic patients.
    Pettersson-Fernholm K, Forsblom C, Perola M, Groop PH, FinnDiane Study Group.
    Kidney Int; 2003 Apr 31; 63(4):1205-10. PubMed ID: 12631336
    [Abstract] [Full Text] [Related]

  • 13. A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women.
    Möllsten A, Vionnet N, Forsblom C, Parkkonen M, Tarnow L, Hadjadj S, Marre M, Parving HH, Groop PH.
    Mol Genet Metab; 2011 May 31; 103(1):66-70. PubMed ID: 21316998
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy.
    Maeda S, Haneda M, Guo B, Koya D, Hayashi K, Sugimoto T, Isshiki K, Yasuda H, Kashiwagi A, Kikkawa R.
    Kidney Int; 2001 Oct 31; 60(4):1428-34. PubMed ID: 11576356
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetes.
    Alvarez-Muñoz P, Mauer M, Kim Y, Rich SS, Miller ME, Russell GB, Lopez-Novoa JM, Caramori ML.
    J Diabetes Complications; 2010 Oct 31; 24(4):242-9. PubMed ID: 19395281
    [Abstract] [Full Text] [Related]

  • 18. The influence of sex on renal function decline in people with Type 2 diabetes.
    de Hauteclocque A, Ragot S, Slaoui Y, Gand E, Miot A, Sosner P, Halimi JM, Zaoui P, Rigalleau V, Roussel R, Saulnier PJ, Hadjadj Samy S, SURDIAGENE Study group.
    Diabet Med; 2014 Sep 31; 31(9):1121-8. PubMed ID: 24773061
    [Abstract] [Full Text] [Related]

  • 19. The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes.
    Lapice E, Monticelli A, Cocozza S, Pinelli M, Cocozza S, Bruzzese D, Riccardi G, Vaccaro O.
    J Transl Med; 2015 Mar 12; 13():85. PubMed ID: 25889595
    [Abstract] [Full Text] [Related]

  • 20. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ, Lewis JB.
    Clin Exp Nephrol; 2003 Mar 12; 7(1):1-8. PubMed ID: 14586737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.